Genetics of migraine and pharmacogenomics: Some considerations

Journal of Headache and Pain

Volumn 8, Issue 6, 2007, Pages 334-339

  Piane, Maria ^a   Lulli, Patrizia ^a   Farinelli, Ivano ^a   Simeoni, Simona ^a   de Filippis, Sergio ^a   Patacchioli, Francesca Romana ^a   Martelletti, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Migraine; Non responder patients; Pharmacogenetics; Pharmacogenomics

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; LYMPHOTOXIN; SUMATRIPTAN; TRIPTAN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANAMNESIS; ARTICLE; CHROMOSOME ABERRATION; CHRONIC DAILY HEADACHE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TARGETING; ENVIRONMENTAL FACTOR; FAMILIAL HEMIPLEGIC MIGRAINE; GENE EXPRESSION PROFILING; GENETIC SUSCEPTIBILITY; HAPLOTYPE MAP; HEREDITY; HUMAN; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PHARMACOGENOMICS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WOLFRAM SYNDROME;

ANALGESICS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIGRAINE DISORDERS; PHARMACOGENETICS;

EID: 38749120999     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-007-0427-2     Document Type: Article

References (54)

1. Wessman M, Kaunisto MA, Kallela M, Palotie A (2004) The molecular genetics of migraine. Ann Med 36:462-473
2. Haan J, Kors EE, Vanmolkot KR et al (2005) Migraine genetics: An update. Curr Pain Headache Rep 9:213-220
3. Russell MB (2005) Tension-type headache in 40-year-olds: A Danish population-based sample of 4000. J Headache Pain 6:441-447
4. Russell MB (2006) Commentary to Comorbidity in Finnish migraine families. J Headache Pain 7:320-321
5. Russell MB (2007) Genetics in primary headaches. J Headache Pain 8:190-195
6. Anttila V, Kallela M, Oswell G et al (2006) Trait components provide tools to dissect the genetic susceptibility of migraine. Am J Hum Genet 79:85-99
7. Honkasalo ML, Kaprio J, Winter T et al (1995) Migraine and concomitant symptoms among 8167 adult twin pairs. Headache 35:70-78
8. Larsson B, Bille B, Pederson NL (1995) Genetic influence in headaches: A Swedish twin study. Headache 35:513-519
9. Gervil M, Ulrich V, Kyvik KO et al (1999) Migraine without aura: A population-based twin study. Ann Neurol 46:606-611
10. Ulrich V, Gervil M, Kyvik KO et al (1999) Evidence of a genetic factor in migraine with aura: A population-based Danish twin study. Ann Neurol 45:242-246
11. Colson NJ, Fernandez F, Lea RA, Griffiths LR (2007) The search for migraine genes: An overview of current knowledge. Cell Mol Life Sci 64:331-344
12. Ophoff RA, Terwindt GM, Vergouwe MN et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543-552
13. + pumpα 2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192-196
14. Dichgans M, Freilinger T, Eckstein G et al (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371-377
15. Zhuchenko O, Bailey J, Bonnen P et al (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 15:62-69
16. Kors EE, Vanmolkot KRJ, Haan J et al (2004) Recent findings in headache genetics. Curr Opin Neurol 17:283-288
17. Terwindt GM, Ophoff RA, van Eijk R et al Dutch Migraine Genetics Research Group (2001) Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 56:1028-1032
18. Kaunisto MA, Tikka PJ, Kallela M et al (2005) Chromosome 19p13 loci in Finnish migraine with aura families. Am J Med Genet B Neuropsychiatr Genet 132:85-89
19. Kors EE, van den Maagdenberg AM, Plomp JJ et al (2002) Calcium channel mutations and migraine. Curr Opin Neurol 15:311-316
20. Colson NJ, Lea RA, Quinlan S et al (2004) The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 5:129-133
21. Lea RA, Ovcaric M, Sundholm J et al (2004) The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 12:2-3
22. McCarthy LC, Hosford DA, Riley JH et al (2001) Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 78:135-149
23. Martelletti P, Lulli P, Morellini M et al (1999) Chromosome 6p-encoded HLA-DR2 determination discriminates migraine without aura from migraine with aura. Hum Immunol 60:69-74
24. Rainero I, Fasano E, Rubino E et al (2005) Association between migraine and HLA-DRB1 gene polymorphisms. J Headache Pain 6:185-187
25. Rainero I, Grimaldi LME, Salani G et al (2004) Association between the tumor necrosis factor-α - 308G/A gene polymorphism and migraine. Neurology 62:141-143
26. Trabace S, Brioli G, Lulli P et al (2002) Tumor necrosis factor gene polymorphism in migraine. Headache 42:341-345
27. Lulli P, Trabace S, Morellini M et al (2005) Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A>G) and migraine. J Headache Pain 6:188-190
28. Rubino E, Ferrero M, Rainero I et al (2007) Association of the C677T polymorphism in the MTHFR gene with migraine: A meta-analysis. Cephalalgia (in press)
29. Kaunisto MA, Kallela M, Hämäläinen E et al (2006) Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 26:1462-1472
30. Peroutka SJ, Price SC, Wilhoit TL, Jones KW (1998) Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 4:14-21
31. Paterna S, Di Pasquale P, D'Angelo A et al (2000) Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 43133-43136
32. De Filippis S, Salvatori E, Farinelli I et al (2007) Chronic daily headache and medication overuse headache: Clinical read-outs and rehabilitation procedures. Clin Ter 158:343-347
33. Cevoli S, Mochi M, Scapoli C et al (2006) A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13:1009-1013
34. Di Lorenzo C, Sances G, Di Lorenzo G et al (2007) The wolframin His611 Arg polymorphism influences medication overuse headache. Neurosci Lett 13:179-184
35. Collins FS (1999) Genetics: An explosion of knowledge is transforming clinical practice. Geriatrics 54:41-47
36. Weinshilboum R (2003) Inheritance and drug response. N Engl J Med 348:529-537
37. Evans WE, McLeod HL (2003) Pharmacogenomics - drug disposition, drug targets, and side effects. N Engl J Med 6:538-549
38. Severino G, Chillotti C, Stochino ME, Del Zompo M (2003) Pharmacogenomics: State of the research and perspectives in clinical application. Neurol Sci 24:S146-S148
39. Stam AH, Haan J, Frants RR et al (2005) Migraine: New treatment options from molecular biology. Expert Rev Neurother 5:653-661
40. Ferrari MD, Haan J (2002) The genetics of migraine: Implication for treatment approaches. J Neural Transm Suppl (63):111-127
41. Fernandez F, Colson NJ, Griffiths L (2007) Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy. Pharmacogenomics 8:609-622
42. van den Maagdenberg AM, Haan J, Terwindt GM, Ferrari MD (2007) Migraine: gene mutations and functional consequences. Curr Opin Neurol 20:299-305
43. Montagna P, Pierangeli G, Cevoli S et al (2005) Pharmacogenetics of headache treatment. Neurol Sci 26:S143-S147
44. Ophoff RA, van den Maagdenberg AM, Roon KI et al (2001) The impact of pharmacogenetics for migraine. Eur J Pharmacol 413:1-10
45. Montagna P (2007) Recent advances in the pharmacogenomics of pain and headache. Neurol Sci 28[Suppl 2]:S208-S212
46. Colombo B, Annovazzi PO, Comi G (2004) Therapy of primary headaches: The role of antidepressants. Neurol Sci 3:S171-S175
47. Tfelt-Hansen P (2007) Acute pharmacotherapy of migraine, tension-type headache, and cluster headache. J Headache Pain 8:127-134
48. Maassen VanDenBrink A, Vergouwe MN, Ophoff RA et al (1998) 5-HT1B receptor polymorphism and clinical response to sumatriptan. Headache 38:288-291
49. Smeraldi E, Zanardi R, Benedetti F et al (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of Fluvoxamine. Mol Psychiatry 3:508-511
50. Cherchi A, Stochino ME, Piccardi MP, Del Zompo M (2001) Role of dopaminergic system in migraine. J Headache Pain 2:S47
51. Del Zompo M, Cherchi A, Palmas MA et al (1998) Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 51:781
52. Phillips KA, Veenstra DL, Oren E et al (2001) Potential role of pharmacogenomics in reducing adverse drug reactions. A systematic review. JAMA 286:2270-2279
53. International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299-1320
54. Nicolas P, Sun F, Li LM (2006) A model-based approach to selection of tag SNPs. BMC Bioinform 7:303